Haemonetics Corporation

8-K Director or officer change; Shareholder vote results Jul 28, 2026 8-K Regulation FD disclosure Jun 5, 2026 10-K Fiscal year ended 2026-03-28 May 20, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change May 1, 2026 8-K Regulation FD disclosure Mar 3, 2026 8-K Regulation FD disclosure Feb 12, 2026 10-Q Quarter ended 2025-12-27 Feb 5, 2026 8-K Results of operations (earnings release) Feb 5, 2026 8-K Other events Jan 9, 2026 10-Q Quarter ended 2025-09-27 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-28 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results Jul 25, 2025 10-K Fiscal year ended 2025-03-29 May 21, 2025 8-K Results of operations (earnings release); Exit or disposal costs May 8, 2025 8-K Director or officer change; Regulation FD disclosure Mar 3, 2025 10-Q Quarter ended 2024-12-28 Feb 6, 2025 8-K Results of operations (earnings release) Feb 6, 2025 8-K Other events Jan 14, 2025 8-K Director or officer change Jan 3, 2025 8-K Other events Dec 3, 2024 10-Q Quarter ended 2024-09-28 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Director or officer change Sep 16, 2024 10-Q Quarter ended 2024-06-29 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K/A Shareholder vote results Jul 30, 2024 8-K Shareholder vote results Jul 25, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity May 29, 2024 8-K Regulation FD disclosure May 23, 2024 8-K Regulation FD disclosure May 21, 2024 10-K Fiscal year ended 2024-03-30 May 20, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation May 1, 2024 8-K Other events Apr 1, 2024 8-K Other events Mar 5, 2024 10-Q Quarter ended 2023-12-30 Feb 8, 2024 8-K Results of operations (earnings release) Feb 8, 2024